The analysis of large, stratified patient populations; various leukocyte subtypes; and cells infected with NSP5/ORF3a SARS-CoV-2 mutants would shed additional light on p62-inflammation interplay in COVID-19. The gene discussed is SPECC1; the disease is COVID-19.